Skip to main content
. 2021 Sep;13(9):5496–5507. doi: 10.21037/jtd-21-924

Figure 1.

Figure 1

EGFR mutation status could not predict the recurrence-free survival in patients with pT1a and pT1b invasive lung adenocarcinoma after excluding LPA and puro GGO. EGFR, epidermal growth factor receptor; LPA, lepidic pattern-predominant adenocarcinoma; GGO, pure ground-glass opacity.